ESLA · Forms 3, 4, 5
Insider trades at Estrella Immunopharma, Inc.
No open-market insider buys or sells at Estrella Immunopharma, Inc. in the last 90 days; 2 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Estrella Immunopharma, Inc. (ESLA) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Cheng Liu | CEO | Option exercise | 100,000 | $0.82 | $82K | Form 4 | |
| Jiandong Xu | Chief Financial Officer | Option exercise | 100,000 | $0.82 | $82K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.